06 January 2020

Fragment events in 2020

Updated as of 29 March - we'll continue to update as we receive more information, particularly for the June meetings.

June 2-4: CHI is launching an inaugural Expanding Chemical Space program as part of their World Pharma Week in Boston, and it looks like there will be several talks on FBDD.

June 15-17:  Although not exclusively fragment-focused, the Eighth NovAliX Conference on Biophysics in Drug Discovery will have lots of relevant talks, and returns to Boston this year. You can read my impressions of the 2018 event here, the 2017 Strasbourg event here, and Teddy's impressions of the 2013 event herehere, and here.

April 13-17 August 24-28: CHI’s Fifteenth Annual Fragment-Based Drug Discovery, the longest-running fragment event, will be held in San Diego April 14-15 August 25-26. This is part of the larger Drug Discovery Chemistry meeting, and includes a short course on FBDD on April 13 August 24. You can read impressions of the 2019 meeting here, the 2018 meeting here, the 2017 meeting here, the 2016 meeting here; the 2015 meeting herehere, and here; the 2014 meeting here and here; the 2013 meeting here and here; the 2012 meeting here; the 2011 meeting here; and 2010 here.

September 20-23: FBLD 2020 will be held for the first time in the original Cambridge (UK). This will mark the eighth in an illustrious series of conferences organized by scientists for scientists. You can read impressions of FBLD 2018FBLD 2016FBLD 2014,  FBLD 2012FBLD 2010, and FBLD 2009. Registration is open, and abstracts are accepted through April 30.

December 17-18: What better way to close the year than in Hawaii? The second Pacifichem Symposium devoted to fragments will be held in Honolulu. Pacifichem conferences are held every 5 years and are designed to bring together scientists from Pacific Rim countries including Australia, Canada, China, Japan, Korea, New Zealand, and the US. Here are my impressions of the 2015 event. Abstract submission is open but closes April 15.

Know of anything else? Please leave a comment or let us know!

No comments: